PCR Biosystems launches kit detection of viral RNA sequences
June 12, 2020PCR Biosystems, the UK-based PCR experts, has launched qPCRBIO Probe 1-Step Virus Detect, a high-concentration 4x RT-qPCR kit designed specifically for ultra-sensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2.
The new kit, which marks the latest addition to PCR Biosystems’ specialized RT-qPCR offering, enables users to add more sample to their reactions to boost analytical sensitivity, even when working with small volume reactions, the company said in a press release.
Consistent with their commitment to supply global healthcare systems with the critical reagents required in the fight against COVID-19, PCR Biosystems has validated the new qPCRBIO Probe 1-Step Virus Detect kit for qualitative detection of the SARS-CoV-2 nucleic acid. Validation has been performed using the Charité (Germany) primer-probe sequences targeting the RdRp and E genes, as well as the Centers for Disease Control and Prevention (USA) recommended sequences targeting specific regions of the N gene. The kit is ideally suited to high-throughput testing of COVID-19 clinical samples, either with laboratory developed assays or as a component of diagnostic testing kits.
Alex Wilson, Co-Founder of PCR Biosystems, explains that RT-qPCR reagent kits are pivotal for successful research and molecular diagnostic projects that aim to establish the course of viral infections. Wislon said that drawing on their PCR expertise and the commitment to delivering best-in-class technologies, PCR Biosystems developed qPCRBIO Probe 1-Step Virus Detect to offer researchers and diagnostic kit manufacturers flexibility in their assay development and ultimate confidence in the quality and accuracy of the results generated.
